Fastlane Launches AI Marketing Platform That Researches, Creates and Runs Campaigns End to End Mountain Valley MD Holdings Announces Voluntary Retraction of a Reported Data Set, No Material Change to Business Plan Anticipated
TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
BioXcel Therapeutics Presents Results from Ongoing Phase 2 Trial of BXCL701 in Combination with KEYTRUDA® in Aggressive Forms of Prostate Cancer at ESMO
BXCL701 plus KEYTRUDA® (pembrolizumab) demonstrates encouraging anti-tumor activity in heavily pre-treated mCRPC patients with adenocarcinoma…
Rezolute Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results and Highlights Recent Company Progress
REDWOOD CITY, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage…
X4 Pharmaceuticals to Participate in Upcoming Investor Conferences
BOSTON, Sept. 15, 2021 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in…
ERYTECH to Host on September 21, 2021 Second Quarter 2021 conference call and Business Update
ERYTECH to Host on September 21, 2021 Second Quarter 2021 conference call and Business Update…
Casma Therapeutics to Present at the UBS Virtual Biotechnology Private Company Symposium
CAMBRIDGE, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) — Casma Therapeutics, Inc., a biotechnology company harnessing…
Travere Therapeutics and Vifor Pharma Announce Licensing Agreement for the Commercialization of Sparsentan in Europe, Australia and New Zealand
Vifor Pharma obtains exclusive commercialization rights for sparsentan in Europe, Australia and New Zealand Travere…
Profile of Entasis Therapeutics ETX0462 Candidate Published in the Journal Nature
Publication Details the Discovery and Preclinical Profile of ETX0462, a First-in-Class Candidate Against Multidrug-Resistant Pathogens…
BioVie to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Virtual Summit
SANTA MONICA, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or…
Crinetics Pharmaceuticals’ Oral SST5 Agonist CRN04777 Demonstrated Pharmacologic Proof-of-Concept with Strong Dose-dependent Suppression of Insulin Secretion in Phase 1 Single Ascending Dose Study
CRN04777 Phase 1 Program Progressing to Multiple Ascending Dose Cohorts to Advance Development as a…
aTyr Pharma Announces Proposed Public Offering of Common Stock
SAN DIEGO, Sept. 15, 2021 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical…
Lowell Herb Co. to Debut New Product at Hall of Flowers Cannabis Tradeshow
California cannabis leader will showcase experimental and innovative grow practices inside immersive pop-up experience LOS…
MedX to Present at Life Sciences Investor Forum on September 16th
MISSISSAUGA, Ontario, Sept. 15, 2021 (GLOBE NEWSWIRE) — MedX Health Corp. (TSXV: MDX) (“MedX” or…
Todos Medical Announces 90-Day Moratorium on Conversions of Convertible Notes and Lockup of Common Stock Sales with Convertible Note Holders
 Univest Securities retained for proposed financing & uplist to national stock exchange  Company to present…
Virbac : availability of half year report
2021 Half-year Financial Report Public release issued on September 15, 2021 after market close We…
NFL BIOSCIENCES: Phase II/III clinical trial for NFL-101 for smoking cessation approved in Franc
NFL Biosciences: Phase II/III clinical trial for NFL-101 for smoking cessation approved in France The…
Virbac: Significant increase in operating profit from ordinary activities for the first half of 2021 due to the sound market performance and dynamism of our business
 CONSOLIDATED FIGURES AS AT JUNE 30thin millions of €   2021 2020 Change 2021/2020…
Nephros to Present at the Virtual MicroCap Leadership Summit
SOUTH ORANGE, NJ, Sept. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Nephros, Inc.(Nasdaq: NEPH), a leading…
AXIM® Biotech Appoints Ophthalmic Industry Veteran Jeff Busby as Senior VP Business Development
Busby to Direct Dry Eye Disease Commercial Launch for Recently Acquired Diagnostic Tech SAN DIEGO,…
Clarus Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
NORTHBROOK, Ill., Sept. 15, 2021 (GLOBE NEWSWIRE) — Clarus Therapeutics Holdings, Inc. (Nasdaq:CRXT), a specialty…